Clues found to early lung transplant failure

May 21, 2018 by Kristina Sauerwein, Washington University in St. Louis
Credit: CC0 Public Domain

Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages the newly transplanted lung.

Now, researchers at Washington University School of Medicine in St. Louis and Northwestern University Feinberg School of Medicine in Chicago have uncovered the precise cells that flow into and harm the soon after transplant. The resulting dysfunction is the leading cause of early death after lung transplantation and contributes to organ rejection that can lead to death months or years later. The discovery, in mice, may lead to drug therapies that target the destructive cells.

"More than 50 percent of lung transplant patients experience some lung damage after a transplant" said Daniel Kreisel, MD, Ph.D., surgical director of lung transplantation at Washington University and Barnes-Jewish Hospital, where he treats patients. "Eliminating this problem would increase the success of ."

The study is published online May 21 in The Journal of Clinical Investigation.

Early typically occurs in the 72 hours following surgery, said Kreisel, the study's senior co-author and a Washington University professor of surgery and of immunology and pathology. When a lung is removed from a donor, it is flushed with a cold preservation fluid and placed on ice, where it is deprived of blood and oxygen. The damage typically occurs after the lung is surgically implanted and the recipient's blood enters the lung for the first time. The recipient's white blood cells seep into the transplanted lung and trigger inflammation that harms the organ's tissue. Affected patients can require extended time on a ventilator in the hospital or even a lung bypass machine to give the new lung a chance to recover.

The condition is a big reason why the success of lung transplants trails behind other solid organ transplants. Five years after lung transplantation, about half of the transplanted lungs are still functioning, according to the U.S. Organ Procurement and Transplantation Network. This compares with five-year organ survival rates of about 70 to 80 percent for liver, heart and kidney transplants.

"Lungs are unique, fragile organs that are particularly susceptible to early damage," said Hsi-Min "Jim" Hsiao, Ph.D., a staff scientist in Kreisel's laboratory and the study's co-first author. "Treatment is largely supportive as the condition is not well-understood. Our research identifies a population of inflammatory cells called monocytes that are key instigators to the inflammation. We are hopeful that these findings will help with the development of new therapies for lung transplant patients."

Studying mice that had undergone lung transplants, the researchers found that monocytes are rapidly released from the spleen after . These cells infiltrate the newly transplanted lung and then produce a protein called interleukin 1 beta, which, in turn, invites in the tissue-damaging known as neutrophils.

"Understanding the mechanisms of this damage is important in developing novel therapeutic agents to treat or prevent the condition in lung transplant patients," Kreisel said. "We already have interleukin-inhibitor drugs for treating other inflammatory diseases. The next step is to test whether this type of drug can tamp down on the inflammatory cells that cause lung failure."

Kreisel shares senior authorship of the study with Ankit Bharat, MD, an associate professor of surgery at Northwestern University. Bharat completed his residency and fellowship training in surgery at Washington University.

"This study is a fundamental advancement in our understanding of early lung injury after transplantation," Bharat said. "We are excited because the findings build on our past research. The work demonstrates the complex yet fascinating interaction between the host's immune and the freshly transplanted lung. The study also introduces clinically relevant therapies that may extend the lives of lung patients."

Besides researchers at Washington University and Northwestern University, scientists at the University of Virginia, Charlottesville, also contributed to the study.

Explore further: New clues found to preventing lung transplant rejection

Related Stories

New clues found to preventing lung transplant rejection

February 25, 2014
Organ transplant patients routinely receive drugs that stop their immune systems from attacking newly implanted hearts, livers, kidneys or lungs, which the body sees as foreign.

Alcohol use before lung transplant increases time in hospital and on ventilator

May 16, 2018
Lung transplant patients who showed evidence of alcohol use before their transplants spent more time in the hospital and on the ventilator, according to a study by Loyola University Chicago and Loyola Medicine researchers.

Researchers investigate the potential of lung restoration for transplant

January 8, 2018
Q: What is the role of lung restoration in lung transplants? How does it work?

Surgeons test technology with potential to expand lung transplant donor pool

April 7, 2016
Michele Coleman lay close to death last fall with end-stage lung disease when she got a second chance at life.

BODE may overestimate transplant benefit in COPD patients

March 6, 2018
COPD remains the leading indication for lung transplantation worldwide and accounts for one third of all lung transplants performed. In order to qualify for a lung transplant, patients receive an evaluation and undergo rigorous ...

Hidden immune cells cause lung transplant failure

June 14, 2017
Northwestern Medicine scientists have discovered that a subset of immune cells called nonclassical monocytes (NCMs), previously unknown to reside in the lungs, play a key role in driving primary graft dysfunction (PGD), the ...

Recommended for you

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

Anticancer drug offers potential alternative to transplant for patients with liver failure

August 15, 2018
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.